121 tracked 13F filers disclose a position in TRDA as of the latest SEC 13F filings, a combined $276.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | $64.0M | 5.1M | —Held | Q1 2026 | |
| 2 | 5AM Venture Management, LLC | $29.9M | 4.1M | —Held | Q2 2026 | |
| 3 | BlackRock, Inc. | $29.8M | 2.4M | ▲+9.8% Added · +212K sh | Q1 2026 | |
| 4 | TCG Crossover Management, LLC | $28.9M | 2.3M | ▲+9.5% Added · +199K sh | Q1 2026 | |
| 5 | Merck & Co., Inc. | $12.8M | 1.7M | ▲New +1.7M sh | Q2 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $15.9M | 1.3M | →First observed position No prior filed position | Q1 2026 | |
| 7 | StepStone Group LP | $5.6M | 761K | —Held | Q2 2026 | |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $5.3M | 717K | ▲+7.5% Added · +50K sh | Q2 2026 | |
| 9 | STATE STREET CORP | $4.4M | 597K | ▲+12% Added · +63K sh | Q2 2026 | |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | $6.6M | 526K | ▲+61% Added · +199K sh | Q1 2026 | |
| 11 | MILLENNIUM MANAGEMENT LLC | $6.6M | 519K | ▲+4.3% Added · +22K sh | Q1 2026 | |
| 12 | JACOBS LEVY EQUITY MANAGEMENT, INC | $4.2M | 334K | ▼−8.0% Reduced · −29K sh | Q1 2026 | |
| 13 | DIMENSIONAL FUND ADVISORS LP | $4.1M | 324K | ▲+19% Added · +51K sh | Q1 2026 | |
| 14 | Nantahala Capital Management, LLC | $2.2M | 301K | ▲+89% Added · +141K sh | Q2 2026 | |
| 15 | NORTHERN TRUST CORP | $3.0M | 235K | ▲+3.8% Added · +9K sh | Q1 2026 | |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.8M | 220K | →First observed position No prior filed position | Q1 2026 | |
| 17 | Woodline Partners LP | $2.7M | 216K | ▲+52% Added · +74K sh | Q1 2026 | |
| 18 | CITADEL ADVISORS LLC | $2.7M | 215K | ▼−27% Reduced · −78K sh | Q1 2026 | |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.7M | 215K | ▼−2.9% Reduced · −7K sh | Q1 2026 | |
| 20 | GOLDMAN SACHS GROUP INC | $2.7M | 213K | ▲+3.7% Added · +8K sh | Q1 2026 | |
| 21 | Longaeva Partners L.P. | $2.6M | 205K | ▲New +205K sh | Q1 2026 | |
| 22 | RENAISSANCE TECHNOLOGIES LLC | $2.6M | 202K | ▼−20% Reduced · −51K sh | Q1 2026 | |
| 23 | BNP PARIBAS FINANCIAL MARKETS | $2.3M | 181K | ▲+0.1% Added · +179 sh | Q1 2026 | |
| 24 | Lynx1 Capital Management LP | $1.3M | 179K | ▼−16% Reduced · −33K sh | Q2 2026 | |
| 25 | MORGAN STANLEY | $2.2M | 176K | ▼−32% Reduced · −84K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in TRDA and 25 added to an existing one, while 14 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 57 funds | $215.6B |
| AMAZON.COM INCAMZN | 56 funds | $102.9B |
| MICROSOFT CORPMSFT | 55 funds | $145.7B |
| ELI LILLY & COLLY | 55 funds | $42.6B |
| UNITEDHEALTH GROUP INCUNH | 55 funds | $16.7B |
| APPLE INCAAPL | 54 funds | $165.2B |
| META PLATFORMS INC-CLASS AMETA | 54 funds | $62.0B |
| TESLA INCTSLA | 54 funds | $38.9B |
| LAM RESEARCH CORPLRCX | 54 funds | $17.1B |
| BRISTOL-MYERS SQUIBB COBMY | 54 funds | $7.6B |
| ROSS STORES INCROST | 54 funds | $6.7B |
| BROADCOM INCAVGO | 53 funds | $87.1B |
Ranked by how many of TRDA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 32K | $231K |
| Sep 3, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 32K | $231K |
| Sep 2, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 25K | $181K |
| Sep 2, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 25K | $181K |
| Sep 1, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 29K | $205K |
| Sep 1, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 29K | $205K |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 44K | $309K |
| Aug 31, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 44K | $309K |
| Aug 28, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 4K | $26K |
| Aug 28, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 4K | $26K |
| Aug 27, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell (S) | 39K | $280K |
| Aug 27, 2026 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell (S) | 39K | $280K |
Connected entities for TRDA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TRDA/capital-change-brief"
Use Arkolith's capital_change_brief for TRDA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TRDA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.